Medical marijuana may have a potential role in oncology for treating anticipatory and refractory chemotherapy-induced nausea and vomiting, for treating refractory cancer pain, and as an antitumor agent, a new review concludes.
WeedLife News Network
Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife Social Network.
Insys Therapeutics Inc. announced Tuesday, July 5, that the United States Food and Drug Administration (FDA) has approved the company’s drug Syndros, an orally administered liquid formulation of the synthetic cannabinoid dronabinol, according to a release.
